80 related articles for article (PubMed ID: 32198704)
1. Correction to: Preclinical Evaluation and Dosimetry of [
Cicone F; Denoël T; Gnesin S; Riggi N; Irving M; Jakka G; Schaefer N; Viertl D; Coukos G; Prior JO
Mol Imaging Biol; 2020 Aug; 22(4):992. PubMed ID: 32198704
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Evaluation and Dosimetry of [
Cicone F; Denoël T; Gnesin S; Riggi N; Irving M; Jakka G; Schaefer N; Viertl D; Coukos G; Prior JO
Mol Imaging Biol; 2020 Aug; 22(4):979-991. PubMed ID: 31993928
[TBL] [Abstract][Full Text] [Related]
3. Internal radiation dosimetry of a
Cicone F; Gnesin S; Denoël T; Stora T; van der Meulen NP; Müller C; Vermeulen C; Benešová M; Köster U; Johnston K; Amato E; Auditore L; Coukos G; Stabin M; Schaefer N; Viertl D; Prior JO
EJNMMI Res; 2019 Jun; 9(1):53. PubMed ID: 31187358
[TBL] [Abstract][Full Text] [Related]
4. Correction to: Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy.
Yuan X; Yang M; Chen X; Zhang X; Sukhadia S; Musolino N; Bao H; Chen T; Xu C; Wang Q; Santoro S; Ricklin D; Hu J; Lin R; Yang W; Li Z; Qin W; Zhao A; Scholler N; Coukos G
Cancer Immunol Immunother; 2018 Feb; 67(2):329-339. PubMed ID: 29313073
[TBL] [Abstract][Full Text] [Related]
5. Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma.
Guo Y; Hu J; Wang Y; Peng X; Min J; Wang J; Matthaiou E; Cheng Y; Sun K; Tong X; Fan Y; Zhang PJ; Kandalaft LE; Irving M; Coukos G; Li C
Eur J Cancer; 2018 Feb; 90():111-121. PubMed ID: 29304474
[TBL] [Abstract][Full Text] [Related]
6. Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells.
Christian S; Winkler R; Helfrich I; Boos AM; Besemfelder E; Schadendorf D; Augustin HG
Am J Pathol; 2008 Feb; 172(2):486-94. PubMed ID: 18187565
[TBL] [Abstract][Full Text] [Related]
7. Tumor Endothelial Marker 1 (TEM1/Endosialin/CD248) Enhances Wound Healing by Interacting with Platelet-Derived Growth Factor Receptors.
Hong YK; Lee YC; Cheng TL; Lai CH; Hsu CK; Kuo CH; Hsu YY; Li JT; Chang BI; Ma CY; Lin SW; Wang KC; Shi GY; Wu HL
J Invest Dermatol; 2019 Oct; 139(10):2204-2214.e7. PubMed ID: 30986375
[TBL] [Abstract][Full Text] [Related]
8. Endosialin (TEM1) as a Diagnostic, Progression, and Prognostic Serum Marker for Patients With Colorectal Cancer-A Preliminary Study.
Pietrzyk Ł; Wdowiak P
Cancer Control; 2020; 27(1):1073274820903351. PubMed ID: 32107922
[TBL] [Abstract][Full Text] [Related]
9. Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248.
Bagley RG; Rouleau C; St Martin T; Boutin P; Weber W; Ruzek M; Honma N; Nacht M; Shankara S; Kataoka S; Ishida I; Roberts BL; Teicher BA
Mol Cancer Ther; 2008 Aug; 7(8):2536-46. PubMed ID: 18723498
[TBL] [Abstract][Full Text] [Related]
10. Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP/90K.
Becker R; Lenter MC; Vollkommer T; Boos AM; Pfaff D; Augustin HG; Christian S
FASEB J; 2008 Aug; 22(8):3059-67. PubMed ID: 18490383
[TBL] [Abstract][Full Text] [Related]
11. Endosialin: molecular and functional links to tumor angiogenesis.
Kontsekova S; Polcicova K; Takacova M; Pastorekova S
Neoplasma; 2016; 63(2):183-92. PubMed ID: 26774137
[TBL] [Abstract][Full Text] [Related]
12. Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors.
Nanda A; Karim B; Peng Z; Liu G; Qiu W; Gan C; Vogelstein B; St Croix B; Kinzler KW; Huso DL
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3351-6. PubMed ID: 16492758
[TBL] [Abstract][Full Text] [Related]
13. Gene targeting and expression analysis of mouse Tem1/endosialin using a lacZ reporter.
Huang HP; Hong CL; Kao CY; Lin SW; Lin SR; Wu HL; Shi GY; You LR; Wu CL; Yu IS
Gene Expr Patterns; 2011; 11(5-6):316-26. PubMed ID: 21402174
[TBL] [Abstract][Full Text] [Related]
14. Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma.
Capone E; Piccolo E; Fichera I; Ciufici P; Barcaroli D; Sala A; De Laurenzi V; Iacobelli V; Iacobelli S; Sala G
Oncotarget; 2017 Sep; 8(36):60368-60377. PubMed ID: 28947977
[TBL] [Abstract][Full Text] [Related]
15. Anti-Endosialin Antibody-Drug Conjugate: Potential in Sarcoma and Other Malignancies.
Rouleau C; Gianolio DA; Smale R; Roth SD; Krumbholz R; Harper J; Munroe KJ; Green TL; Horten BC; Schmid SM; Teicher BA
Mol Cancer Ther; 2015 Sep; 14(9):2081-9. PubMed ID: 26184481
[TBL] [Abstract][Full Text] [Related]
16. Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors.
Brady J; Neal J; Sadakar N; Gasque P
J Neuropathol Exp Neurol; 2004 Dec; 63(12):1274-83. PubMed ID: 15624764
[TBL] [Abstract][Full Text] [Related]
17. Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization.
Bagley RG; Honma N; Weber W; Boutin P; Rouleau C; Shankara S; Kataoka S; Ishida I; Roberts BL; Teicher BA
Microvasc Res; 2008 Nov; 76(3):180-8. PubMed ID: 18761022
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Preclinical Evaluation of (177)Lu-CHX-A"-DTPA-Rituximab as a Radioimmunotherapeutic Agent for Non-Hodgkin's Lymphoma.
Kameswaran M; Pandey U; Dhakan C; Pathak K; Gota V; Vimalnath KV; Dash A; Samuel G
Cancer Biother Radiopharm; 2015 Aug; 30(6):240-6. PubMed ID: 26066665
[TBL] [Abstract][Full Text] [Related]
19. A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y.
Price EW; Edwards KJ; Carnazza KE; Carlin SD; Zeglis BM; Adam MJ; Orvig C; Lewis JS
Nucl Med Biol; 2016 Sep; 43(9):566-576. PubMed ID: 27419360
[TBL] [Abstract][Full Text] [Related]
20. Novel monoclonal antibodies specific for CTLD-SSC and sialomucin domains of endosialin, a mural cell marker of tumor vasculature.
Kontseková S; Ohradanova Repic A; Polčicová K; Tuomaala P; Pastorek J; Pastoreková S; Parkkila S; Baráthová M
Int J Oncol; 2012 Oct; 41(4):1365-72. PubMed ID: 22824847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
